Hogenesch; John B.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Hogenesch; John B..The latest application filed is for "novel chronotherapy based on circadian rhythms".

Company Profile

1.8.16

Hogenesch; John B. - Rose Valley PA
Hogenesch; John B. - Cincinnati OH
Hogenesch; John B. - Philadelphia PA
Hogenesch; John B. - Encinitas CA
Hogenesch; John B - Encinitas CA
Hogenesch; John B. - San Diego CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Novel Chronotherapy Based On Circadian Rhythms App 20210137911 - Hogenesch; John B. ; et al.	2021-05-13
Systems And Method For Analyzing Operational Rhythms In Hospital Treatment App 20210098121 - Ruben; Marc D. ; et al.	2021-04-01
Novel Chronotherapy Based On Circadian Rhythms App 20180071272 - HOGENESCH; JOHN B. ; et al.	2018-03-15
Recombinant Cells And Methods Of Using Such Cells To Identify Circadian Rhythm Modulators App 20160186209 - Liu; Andrew C. ; et al.	2016-06-30
Urocortin proteins and uses thereof Grant 8,044,025 - Vale, Jr. , et al. October 25, 2	2011-10-25
Urocortin Proteins And Uses Thereof App 20100168021 - Vale, JR.; Wylie Walker ; et al.	2010-07-01
Urocortin proteins and uses thereof Grant 7,638,607 - Vale, Jr. , et al. December 29, 2	2009-12-29
Screening Assay To Identify Modulators Of The Sleep/wake Cycle App 20090142793 - Kay; Steve A. ; et al.	2009-06-04
cDNAs and proteins involved in hypoxia, circadian and orphan signal transduction pathways, and methods of use Grant 7,501,489 - Bradfield , et al. March 10, 2	2009-03-10
Screening assay to identify modulators of the sleep/wake cycle Grant 7,427,489 - Kay , et al. September 23, 2	2008-09-23
Methods and compositions for modulating activator protein 1 Grant 7,344,833 - Chanda , et al. March 18, 2	2008-03-18
Urocortin proteins and uses thereof App 20070191592 - Vale; Wylie W. JR. ; et al.	2007-08-16
Urocortin proteins and uses thereof Grant 7,223,846 - Vale, Jr. , et al. May 29, 2	2007-05-29
cDNAs and proteins involved in hypoxia, circadian and orphan signal transduction pathways, and methods of use Grant 7,105,647 - Bradfield , et al. September 12, 2	2006-09-12
cDNAs and proteins involved in hypoxia, circadian and orphan signal transduction pathways, and methods of use App 20060084798 - Bradfield; Christopher A. ; et al.	2006-04-20
Urocortin proteins and uses thereof App 20050191650 - Vale, Wylie W. JR. ; et al.	2005-09-01
Methods and compositions for modulating circadian rhythm App 20050186138 - Hogenesch, John B. ; et al.	2005-08-25
Methods for treating circadian rhythm phase disturbances App 20050149993 - Panda, Satchidananda ; et al.	2005-07-07
Urocortin proteins and uses thereof Grant 6,838,274 - Vale, Jr. , et al. January 4, 2	2005-01-04
Methods and compositions for modulating P53 transcription factor App 20040171035 - Huang, Qihong ; et al.	2004-09-02
Methods and compositions for modulating activator protein 1 App 20040146903 - Chanda, Sumit ; et al.	2004-07-29
Genomics-driven high speed cellular assays, development thereof, and collections of cellular reporters App 20040076954 - Caldwell, Jeremy S. ; et al.	2004-04-22
Identification of cellular targets for biologically active molecules App 20030170642 - Caldwell, Jeremy S. ; et al.	2003-09-11
Urocortin proteins and uses thereof App 20020127221 - Vale, Wylie W. JR. ; et al.	2002-09-12

Company Registrations

NCAGE Code	4JMD6	HOGENESCH JOHN B
CAGE Code	4JMD6	HOGENESCH, JOHN B

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.